Abstract:Metformin exerts its anticancer effect through two mechanisms, directly affecting the tumor and indirectly reducing systemic insulin levels. The anticancer effects of aspirin occur by inhibiting Cyclooxygenase (COX)-2. COX-2 is absent in many cell types under normal conditions and increases under pathological conditions such as cancer. This study aims to investigate the effect of metformin and aspirin and their combination of them on A549 and PC3 cell lines. Metformin and aspirin were investigated separately and in combination on two cancer cell lines, A549 and PC3. The examined groups include the negative control of untreated cells and the positive control of cisplatin and drugs at concentrations of 15, 10, and 20 μg/ mL to investigate the mechanism of oxidative stress factors (reactive oxygen species, lipid peroxidation, Glutathione (GSH)) and apoptosis (lactate dehydrogenase). The results showed that aspirin, metformin, and their combination could affect cancer cell growth by damaging mitochondria, releasing reactive oxygen species, and activating the oxidative stress pathway. Also, these two drugs show the activation of the apoptotic pathway in cancer cells by increasing the lactate dehydrogenase factor and releasing it from the cells. By disrupting the balance of oxidants and antioxidants in the cell, metformin and aspirin cause an increase in the level of reactive oxygen species and a decrease in the level of glutathione reserves, followed by an increase in the level of lipid peroxidation and a decrease in cell viability. Unlike common chemotherapy drugs, these drugs have no known severe side effects; Therefore, in the not-so-distant future, these drugs can also be used as anticancer drugs. Highlights: Metformin and aspirin, commonly used drugs for diabetes and inflammation, inhibit the growth of cancer cell lines, A549 and PC3.Metformin and aspirin, either separately or in combination, can potentially impede cancer cell growth by disrupting mitochondrial function, inducing the release of reactive oxygen species (ROS), and activating oxidative stress pathways.Furthermore, these drugs can trigger apoptosis, a programmed cell death mechanism, in cancer cells by increasing lactate dehydrogenase (LDH) levels and facilitating its release from the cells.

Aspirin and Metformin Exhibit Antitumor Activity in Murine Breast Cancer.

Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Aspirin Disrupts the Mtor-Raptor Complex and Potentiates the Anti-Cancer Activities of Sorafenib Via Mtorc1 Inhibition.

Aspirin Inhibits Cancer Metastasis and Angiogenesis Via Targeting Heparanase

Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action

Metformin Mitigates DPP-4 Inhibitor-Induced Breast Cancer Metastasis via Suppression of mTOR Signaling

Metformin plays an antitumor role by downregulating inhibitory cells and immune checkpoint molecules while activating protective immune responses in breast cancer

Anti-tumor Effect of Metformin in Breast Cancer

The Antidiabetic Drug Metformin Inhibits The Proliferation Of Bladder Cancer Cells In Vitro And In Vivo

Aspirin Regulation of C-Myc and Cyclind1 Proteins to Overcome Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells

Metformin reduces basal subpopulation and attenuates mammary epithelial cell stemness in FVB/N mice

Effect of metformin on apoptosis, cell cycle arrest migration and invasion of A498 cells.

Metformin Inhibits the Function of Granulocytic Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice.

Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis

The Tgf-Beta Induced Gene, Pmepa1, Attenuates Antitumor Efficacy Of Aspirin In Triple-Negative Breast Cancer By Regulating Tgf-Beta 1

PlGF Signaling and Macrophage Repolarization Contribute to the Anti-Neoplastic Effect of Metformin

Aspirin Inhibits Proliferation and Metastasis of Canine Mammary Gland Tumor Cells Through Wnt Signaling Axis.

Additive Cytotoxic and Colony-Formation Inhibitory Effects of Aspirin and Metformin on PI3KCA-Mutant Colorectal Cancer Cells

Aspirin Inhibits the Proliferation of Canine Mammary Gland Tumor Cells in Vitro and in Vivo

Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway

Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation